Skip to content

Assessment pityriasis versicolor´s treatmenmt comparing Ketoconazol 2 % cream with Benzoyl Peroxide cream 5% isolateds and with these two together in cream

Randomized double blind clinical trial to compare Ketoconazol 2 % with Benzoyl Peroxide 5% isolatedly and one of them isolatedly with both together in Pityriasis Versicolor treatment

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3jtxjs
Enrollment
Unknown
Registered
2015-09-27
Start date
2015-10-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pityriasis versicolor.

Interventions

Group1- Experimental group- Ketoconazol 2% with benzoyl peroxide 5% cream- Apply over the lesions at night for thirty nights.(108 patients) Group2-Control group-Ketoconazol 2% cream- Apply over the le
Drug

Sponsors

Universidade Federal de Pernambuco
Lead Sponsor
Tárcio dos Santos Pereira
Collaborator

Eligibility

Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Voluntary, mael or femael; age 18 years old or more who has clinical of pityriasis versicolor and agree to take part in the study by consent information term

Exclusion criteria

Exclusion criteria: Patients who referring positive HI;, diabetic; pregnant; patient who taken immunossupressor's drugs; patients with allergic history to any drugs of the study; patients that have antimycotic in the last 30 days

Design outcomes

Primary

MeasureTime frame
Absence of the disease in 3 months and in 1 year verifiabel by physical exam and micological direct test over 75% of patients 3 months after treatment and over 45 % of patients 1 year after treatment.

Secondary

MeasureTime frame
Verification of the cure checked by absence of spots and if they are present for the negative micological test.

Countries

Brazil

Contacts

Public ContactTárcio Pereira

Universidade Federal de Pernambuco

tarciotito@hotmail.com558134294719

Outcome results

None listed

Source: REBEC (via WHO ICTRP)